CSS LLC’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
2,757
+160
+6% +$79.7K 0.09% 197
2025
Q4
$1.27M Sell
2,597
-550
-17% -$256K 0.07% 258
2025
Q3
$1.32M Sell
3,147
-510
-14% -$172K 0.08% 249
2025
Q2
$1.05M Sell
3,657
-320
-8% -$95.6K 0.07% 320
2025
Q1
$1.23M Buy
3,977
+1,650
+71% +$565K 0.09% 227
2024
Q4
$821K Buy
2,327
+280
+14% +$103K 0.05% 401
2024
Q3
$734K Buy
2,047
+300
+17% +$101K 0.04% 380
2024
Q2
$557K Sell
1,747
-503
-22% -$133K 0.04% 454
2024
Q1
$517K Sell
2,250
-300
-12% -$67.7K 0.04% 436
2023
Q4
$561K Buy
2,550
+100
+4% +$23K 0.04% 377
2023
Q3
$553K Sell
2,450
-350
-13% -$80.6K 0.05% 356
2023
Q2
$618K Buy
2,800
+300
+12% +$66.5K 0.05% 342
2023
Q1
$560K Buy
2,500
+700
+39% +$173K 0.04% 294
2022
Q4
$501K Sell
1,800
-100
-5% -$25.2K 0.03% 381
2022
Q3
$398K Sell
1,900
-400
-17% -$89.4K 0.02% 583
2022
Q2
$542K Buy
2,300
+300
+15% +$61K 0.03% 551
2022
Q1
$359K Buy
+2,000
New +$381K 0.02% 696
2015
Q2
Hold
0
834
2015
Q1
Hold
0
818

Other funds holding UTHR